Zobrazeno 1 - 10
of 248
pro vyhledávání: '"Paul van Houtte"'
Autor:
Sofian Benkhaled, Kadiatou Diakité, Nicolas Jullian, Sara Poeta, Christophe Vandekerkhove, Paul Van Houtte, Dirk Van Gestel, Alex De Caluwé
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Purpose / objective This study compares the dosimetric plans of three distinct boost modalities in cervical cancer (CC): intracavitary (IC) with tandem/ovoids brachytherapy (BT), IC + interstitial (IS) BT, and Stereotactic-Body-Radiotherapy
Externí odkaz:
https://doaj.org/article/08eb272a25c14874bb1d53c27c8ba955
Autor:
Mahmut Ozsahin, René-Olivier Mirimanoff, Juliett Thariat, Xu Shan Sun, Banu Atalar, Yasmin Lassen-Ramshad, Gamze Ugurluer, Sunil Krishnan, Christopher Hallemeier, Paul Van Houtte, Marco Krengli, Lan Jun Zhang, Kenneth Chang, Ryan Funk, Jessica Rooney, Robert Miller
Publikováno v:
Rare Tumors, Vol 6, Iss 3 (2014)
The Rare Cancer Network (RCN) was formed in the early 1990’s to create a global network that could pool knowledge and resources in the studies of rare malignancies whose infrequency prevented both their study with prospective clinical trials. To da
Externí odkaz:
https://doaj.org/article/0958c115ab084b16aec0bbf433f99954
Autor:
Zhengfei Zhu, Jianjiao Ni, Xuwei Cai, Shengfa Su, Hongqing Zhuang, Zhenzhou Yang, Ming Chen, Shenglin Ma, Conghua Xie, Yaping Xu, Jiancheng Li, Hong Ge, Anwen Liu, Lujun Zhao, Chuangzhou Rao, Congying Xie, Nan Bi, Zhouguang Hui, Guangying Zhu, Zhiyong Yuan, Jun Wang, Lina Zhao, Wei Zhou, Chai Hong Rim, Arturo Navarro-Martin, Ben G. L. Vanneste, Dirk De Ruysscher, J. Isabelle Choi, Jacek Jassem, Joe Y. Chang, Lucyna Kepka, Lukas Käsmann, Michael T. Milano, Paul Van Houtte, Rafal Suwinski, Alberto Traverso, Hiroshi Doi, Yang-Gun Suh, Georges Noël, Natsuo Tomita, Roman O. Kowalchuk, Terence T. Sio, Baosheng Li, Bing Lu, Xiaolong Fu
Publikováno v:
Translational Lung Cancer Research, 11, 1763-1795. AME Publishing Company
Background: Lung cancer is the leading cause of cancer-related death worldwide, with non-small cell lung cancer (NSCLC) accounting for most cases. While radiotherapy has historically served as a palliative modality in metastatic NSCLC, considerable a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::140c02741b295d0cba9538b041139571
https://doi.org/10.21037/tlcr-22-644
https://doi.org/10.21037/tlcr-22-644
Autor:
Zhenyang, Zhang, Shuhan, Xie, Weijing, Cai, Zhi-Nuan, Hong, Chuangcai, Yang, Yukang, Lin, Jiafu, Zhu, Zhiwei, Lin, Daniel C, Christoph, Hanibal, Bohnenberger, Lucyna, Kepka, Wolfgang M, Brueckl, Paul, Van Houtte, Mingqiang, Kang, Jiangbo, Lin
Publikováno v:
Transl Lung Cancer Res
BACKGROUND: Large part of patients of stage IB non-small cell lung cancer (IB NSCLC) may suffer recurrence after surgery. This study is to determine risk factors and establish a nomogram for postoperative recurrence and to provide a reference for adj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a9ab7024c38195859ea1827e4b0632a
https://doi.org/10.21037/tlcr-21-1038
https://doi.org/10.21037/tlcr-21-1038
Autor:
Ben J. Slotman, Nicolaus Andratschke, Paul Van Houtte, Cécile Le Péchoux, Paul Martin Putora, Rafal Dziadziuszko, Dirk De Ruysscher, Esther G.C. Troost, José Belderbos, Ursula Nestle, Fiona McDonald, Joachim Widder, Umberto Ricardi, X. Geets, Markus Glatzer, Sara Ramella, Matthias Guckenberger, Yolande Lievens, Karin Dieckmann, Farkhad Manapov, Krisztian Süveg, Christoph Pöttgen, Stéphanie Peeters, Corinne Faivre-Finn
Publikováno v:
Süveg, K, le Pechoux, C, Faivre-Finn, C, Putora, P M, de Ruysscher, D, Widder, J, van Houtte, P, Troost, E G C, Slotman, B J, Ramella, S, Pöttgen, C, Peeters, S T H, Nestle, U, McDonald, F, Dziadziuszko, R, Belderbos, J, Ricardi, U, Manapov, F, Lievens, Y, Geets, X, Dieckmann, K, Guckenberger, M, Andratschke, N & Glatzer, M 2021, ' Role of Postoperative Radiotherapy in the Management for Resected NSCLC – Decision Criteria in Clinical Routine Pre-and Post-LungART ', Clinical Lung Cancer, vol. 22, no. 6, pp. 579-586 . https://doi.org/10.1016/j.cllc.2021.08.007
Clinical lung cancer, Vol. 22, no.6, p. 579-586 (2021)
Clinical Lung Cancer, 22(6), 579-586. Elsevier
Clinical Lung Cancer 22(2021)6, 579-586
Clinical Lung Cancer, 22(6), 579-586. CIG Media Group, L.P.
Clinical lung cancer, Vol. 22, no.6, p. 579-586 (2021)
Clinical Lung Cancer, 22(6), 579-586. Elsevier
Clinical Lung Cancer 22(2021)6, 579-586
Clinical Lung Cancer, 22(6), 579-586. CIG Media Group, L.P.
The role of postoperative radiation therapy (PORT) in stage III N2 nonsmall cell lung cancer patients remains controversial. PORT is still widely used among European thoracic radiation oncology experts with a clear decrease in its use for patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baf46931e65b1c10e56a0a3ff22721fd
http://www.scopus.com/inward/record.url?scp=85116233138&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85116233138&partnerID=8YFLogxK
Autor:
Lewis, Florence, Merckaert, Isabelle, Liénard, Aurore, Libert, Yves, Etienne, Anne-Marie, Reynaert, Christine, Slachmuylder, Jean-Louis, Scalliet, Pierre, Paul, Van Houtte, Coucke, Philippe, Salamon, Emile, Razavi, Darius
Publikováno v:
In Radiotherapy and Oncology May 2014 111(2):276-280
Autor:
Jean-Luc Van Laethem, Séverine Racadot, Pascal Hammel, Dewi Vernerey, Florence Huguet, Paul Van Houtte, Bengt Glimelius, David Goldstein, Nigel Spry, Paul Giraud, Michael Gubanski
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:993-1002
Purpose The LAP07 multicenter randomized study assessed whether chemoradiation therapy increases overall survival versus continuation chemotherapy in patients whose locally advanced pancreatic cancer was controlled after 4 months of induction chemoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6df6c4dead9d70599fe6d738699f195
https://doi.org/10.1016/j.ijrobp.2021.01.055
https://doi.org/10.1016/j.ijrobp.2021.01.055
Autor:
Sara Ramella, Stéphanie Peeters, Yolande Lievens, Krisztian Süveg, Cécile Le Péchoux, Markus Glatzer, Ben J. Slotman, Joachim Widder, Nicolaus Andratschke, Christoph Pöttgen, Corinne Faivre-Finn, Umberto Ricardi, Farkhad Manapov, Rafal Dziadziuszko, Karin Dieckmann, Paul Martin Putora, Dirk De Ruysscher, X. Geets, Matthias Guckenberger, Esther G.C. Troost, Ursula Nestle, José Belderbos, Fiona McDonald, Paul Van Houtte
Publikováno v:
Radiotherapy and Oncology 154(2021), 269-273
Radiotherapy and Oncology, 154, 269-273. Elsevier Ireland Ltd
Radiotherapy and Oncology, 154, 269-273. Elsevier Ireland Ltd
Background: Whole brain radiotherapy (WBRT) is a common treatment option for brain metastases secondary to non-small cell lung cancer (NSCLC). Data from the QUARTZ trial suggest that WBRT can be omitted in selected patients and treated with optimal s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8326094b3ceaee02b30211edc97cb34
https://doi.org/10.1016/j.radonc.2020.10.043
https://doi.org/10.1016/j.radonc.2020.10.043
Many major technical developments have occurred during the last decades in radiotherapy: our efficacy has improved with less toxicity. Nowadays, it allows us to challenge the role of surgery as a local modality for lung cancer both for early, advance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c360d3018181a9aaf91e43d36fcc15bb
https://doi.org/10.5772/intechopen.94486
https://doi.org/10.5772/intechopen.94486
Autor:
Filippo de Marinis, Fiona H Blackhall, Martin Früh, Dirk De Ruysscher, Cecila Le Pechoux, Mary O’ Brien, Enriqueta Felip, Silvia Novello, Sara Ramella, Paul Martin Putora, Markus Glatzer, Rafal Dziadziuszko, L. Arés, José Belderbos, Fiona McDonald, Christoph Pöttgen, Esther G.C. Troost, Ursula Nestle, Benjamin Besse, Martin Reck, Federico Cappuzzo, Joachim Widder, Raffaele Califano, Paul Van Houtte, Françoise Mornex, Virginie Westeel, Pilar Garrido, Ben J. Slotman, Stéphanie Peeters, Corinne Faivre-Finn
Publikováno v:
Putora, P M, Glatzer, M, Belderbos, J, Besse, B, Blackhall, F, Califano, R, Cappuzzo, F, de Marinis, F, Dziadziuszko, R, Felip, E, Faivre-Finn, C, Früh, M, Garrido, P, le Pechoux, C, McDonald, F, Nestle, U, Novello, S, O‘Brien, M, Paz Ares, L, Peeters, S, Pöttgen, C, Ramella, S, Reck, M, Slotman, B, Troost, E G C, van Houtte, P, Westeel, V, Widder, J, Mornex, F & de Ruysscher, D 2019, ' Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts ', Radiotherapy and Oncology, vol. 133, pp. 163-166 . https://doi.org/10.1016/j.radonc.2018.12.014
Radiotherapy and Oncology, 133, 163-166. Elsevier Ireland Ltd
Radiotherapy and Oncology, 133, 163-166. Elsevier Ireland Ltd
Background: Due to conflicting results between major trials the role of prophylactic cranial irradiation (PCI) in stage IV small cell lung cancer (SCLC) is controversial.Methods: We obtained a list of 13 European experts from both the European Societ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5d2924e25a6fefefd7ddc020d3c8ab9
https://cris.maastrichtuniversity.nl/en/publications/0b237113-6d72-47b7-95f5-5d4c1d59c191
https://cris.maastrichtuniversity.nl/en/publications/0b237113-6d72-47b7-95f5-5d4c1d59c191